SCHEMBL29930804

SCHEMBL29930804

COc1ccc(-c2n[nH]c3ncc(Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc23)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 6/20 0.70
DYRK1B Q9Y463 5/20 0.70
RAB9A P51151 2/20 0.42
PIK3CA P42336 1/20 0.41
MAPT P10636 2/20 0.40
CNR1 P21554 1/20 0.40
CNR2 P34972 1/20 0.40
GPR55 Q9Y2T6 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
CLK1 P49759 1/20 0.40
RUVBL1 Q9Y265 1/20 0.40
ACP1 P24666 1/20 0.39
KDM4E B2RXH2 2/20 0.39
THRB P10828 1/20 0.39
BRAF P15056 1/20 0.39
DHFR P00374 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29930701 0.82 DYRK1B (0.67) DYRK1ADYRK1BRAB9AMAPTACP1
SCHEMBL29930670 0.78 DYRK1B (0.70) DYRK1ADYRK1BRAB9APIK3CABRAF
SCHEMBL29930851 0.74 DYRK1B (0.73) DYRK1ADYRK1BMAPTMAPK1
SCHEMBL28562998 0.73 DYRK1B (0.61) DYRK1ADYRK1BRAB9AMAPTKDM4E
SCHEMBL29930500 0.73 DYRK1A (0.47) DYRK1ADYRK1BRAB9AMAPTKDM4E
SCHEMBL29930889 0.71 DYRK1B (0.69) DYRK1ADYRK1BMAPTBRAFMAPK1
SCHEMBL29930898 0.69 DYRK1A (0.65) DYRK1ADYRK1B
SCHEMBL29930763 0.68 DYRK1B (0.71) DYRK1ADYRK1BRAB9AMAPTBRAF
SCHEMBL1592841 0.68 MAP2K4 (0.45) DYRK1ARAB9ACLK1KDM4EMAPK1
SCHEMBL8742187 0.68 KMT2A (0.48) DYRK1ADYRK1BMAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO claimed
WO-2022235097-A1 PHARMACEUTICAL COMPOSITION CONTAINING NOVEL PYRAZOLO[3,4-B]PYRIDINE DERIVATIVE FOR PREVENTION OR TREATMENT OF METABOLIC DISEASE INCLUDING OBESITY AND DIABETES MELLITUS OR NONALCOHOLIC STEATOHEPATITIS 한국화학연구원 2022-11-10 WO disclosed